AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
AbbVie said on Thursday it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market
2023-11-30 20:52
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech
2023-10-23 13:49
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:18
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:19
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:26
Zuckerberg Is Helping to Propel Chicago’s Biotech Ambitions
For about a year, Northwestern University professor Shana Kelley and a group of more than 20 Chicago scientists
2023-06-07 22:51
US FDA approves Genmab-AbbVie's blood cancer therapy
(Reuters) -The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab's blood cancer therapy for adult
2023-05-20 01:59
Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
2023-05-19 05:29
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:15